Higher platelet reactivity and platelet-monocyte complex formation in Gram-positive sepsis compared to Gram-negative sepsis

Platelets

Volumn 28, Issue 6, 2017, Pages 595-601

  Tunjungputri, Rahajeng N ^a,b   van de Heijden, Wouter ^a   Urbanus, Rolf T ^b   de Groot, Philip G ^b   van der Ven, Andre ^a,c   de Mast, Quirijn ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DIPONEGORO UNIVERSITY   (Indonesia)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

gram negative; Gram positive; infection; platelet activation; sepsis

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTIVITAMIN K; BETA THROMBOGLOBULIN; C REACTIVE PROTEIN; COLLAGEN; COLLAGEN RELATED PEPTIDE; FIBRINOGEN; PADGEM PROTEIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE FACTOR 4; UNCLASSIFIED DRUG; PPBP PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BLOOD SAMPLING; CASE CONTROL STUDY; CATHETER INFECTION; CHOLECYSTITIS; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIABETIC FOOT; ENDOMETRITIS; ERYSIPELAS; FEMALE; FLOW CYTOMETRY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; GRAM POSITIVE BACTERIUM; GRAM POSITIVE INFECTION; GRAM POSITIVE SEPSIS; HUMAN; HUMAN CELL; MALE; MONOCYTE; PLATELET REACTIVITY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; SEPSIS; THROMBOCYTE; THROMBOCYTE MEMBRANE; UROSEPSIS; BLOOD; COMPARATIVE STUDY; GRAM NEGATIVE INFECTION; METABOLISM; MIDDLE AGED; PATHOLOGY; THROMBOCYTE ACTIVATION; VERY ELDERLY;

ADENOSINE DIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; BETA-THROMBOGLOBULIN; BLOOD PLATELETS; C-REACTIVE PROTEIN; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; MONOCYTES; P-SELECTIN; PLATELET ACTIVATION; PLATELET FACTOR 4; SEPSIS;

EID: 85007478252     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537104.2016.1252837     Document Type: Article

References (41)

1. Semple JW, Italiano JE, Jr., Freedman J., Platelets and the immune continuum. Nat Rev Immunol 2011;11:264–274.
2. Thomas MR, Storey RF., The role of platelets in inflammation. Thrombosis Haemostasis 2015;114:449–458.
3. von Hundelshausen P, Weber C., Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007;100:27–40.
4. Ford I, Douglas CW., The role of platelets in infective endocarditis. Platelets 1997;8:285–294.
5. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P., Risk of myocardial infarction and stroke after acute infection or vaccination. N Eng J Med 2004;351:2611–2618.
6. Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H., Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 1998;351:1467–1471.
7. Clayton TC, Thompson M, Meade TW., Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J 2008;29:96–103.
8. Weidenmaier C, Peschel A., Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol 2008;6:276–287.
9. Musher DM, Rueda AM, Kaka AS, Mapara SM., The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis 2007;45:158–165.
10. Dalager-Pedersen M, Sogaard M, Schonheyder HC, Nielsen H, Thomsen RW., Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study. Circulation 2014;129:1387–1396.
11. Dong M, Liu T, Li G., Association between acute infections and risk of acute coronary syndrome: a meta-analysis. Int J Cardiol 2011;147:479–482.
12. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG, Jr., Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Internal Med 2009;169:463–473.
13. Hamzeh-Cognasse H, Damien P, Chabert A, Pozzetto B, Cognasse F, Garraud O., Platelets and Infections–Complex Interactions with Bacteria. Front Immun 2015;6:82.
14. Tunjungputri RN, de Jonge MI, de Greeff A, van Selm S, Buys H, Harders-Westerveen JF, et al. Invasive pneumococcal disease leads to activation and hyperreactivity of platelets. Thrombosis Res 2016;144:123–126.
15. Ward JR, Bingle L, Judge HM, Brown SB, Storey RF, Whyte MK, et al. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thrombosis Haemostasis 2005;94:831–838.
16. Sheu JR, Hung WC, Kan YC, Lee YM, Yen MH., Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets. Br J Haematol 1998;103:29–38.
17. Montrucchio G, Bosco O, Del Sorbo L, Pecetto PF, Lupia E, Goffi A, et al. Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. Thrombosis Haemostasis 2003;90:872–881.
18. Damien P, Cognasse F, Eyraud MA, Arthaud CA, Pozzetto B, Garraud O, et al. LPS stimulation of purified human platelets is partly dependent on plasma soluble CD14 to secrete their main secreted product, soluble-CD40-Ligand. BMC Immun 2015;16:3.
19. Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S., Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 2003;73:232–241.
20. Storey RF, Judge HM, Wilcox RG, Heptinstall S., Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin. Thrombosis Haemostasis 2002;88:488–494.
21. Tunjungputri RN, Van Der Ven AJ, Schonsberg A, Mathan TS, Koopmans P, Roest M, et al. Reduced platelet hyperreactivity and platelet-monocyte aggregation in HIV-infected individuals receiving a raltegravir-based regimen. AIDS (London, England). 2014;28:2091–2096.
22. van Bladel ER, Laarhoven AG, van der Heijden LB, Heitink-Pollé KM, Porcelijn L, van der Schoot CE, et al. Functional platelet defects in children with severe chronic ITP as tested with two novel assays applicable for low platelet counts. Blood. 2014:blood-2013-08-519686.
23. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI., Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104:1533–1537.
24. Snoep JD, Roest M, Barendrecht AD, De Groot PG, Rosendaal FR, Van Der Bom JG. High platelet reactivity is associated with myocardial infarction in premenopausal women: a population-based case-control study. JTH 2010;8:906–913.
25. Kerrigan SW, Kaw G, Hogan M, Penadés J, Litt D, Fitzgerald DJ, et al. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine–aspartate repeat protein SdrE and protein A. Mol Microbiol 2002;44:1033–1044.
26. Kerrigan SW, Clarke N, Loughman A, Meade G, Foster TJ, Cox D., Molecular Basis for Staphylococcus aureus–Mediated Platelet Aggregate Formation Under Arterial Shear In Vitro. Arteriosclerosis, Thrombosis, Vasc Biol 2008;28:335–340.
27. Arman M, Krauel K, Tilley DO, Weber C, Cox D, Greinacher A, et al. Amplification of bacteria-induced platelet activation is triggered by FcgammaRIIA, integrin alphaIIbbeta3, and platelet factor 4. Blood 2014;123:3166–3174.
28. Sheu JR, Lee CR, Lin CH, Hsiao G, Ko WC, Chen YC, et al. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. Thrombosis Haemostasis 2000;83:777–784.
29. Moriarty RD, Cox A, McCall M, Smith SG, Cox D., Escherichia coli induces platelet aggregation in an FcgammaRIIa-dependent manner. JTH 2016;14:797–806.
30. Watson CN, Kerrigan SW, Cox D, Henderson IR, Watson SP, Arman M., Human platelet activation by Escherichia coli: roles for FcgammaRIIA and integrin alphaIIbbeta3. Platelets 2016; 27:535–540.
31. Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB, et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol (Baltimore, Md: 1950). 2009;182:7997–8004.
32. Schrottmaier WC, Kral JB, Zeitlinger M, Salzmann M, Jilma B, Assinger A., Platelet activation at the onset of human endotoxemia is undetectable in vivo. Platelets 2016; 27:479–483.
33. Thomas MR, Outteridge SN, Ajjan RA, Phoenix F, Sangha GK, Faulkner RE, et al. Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model. Arteriosclerosis, Thrombosis, Vasc Biol 2015;35:2562–2570.
34. Corrales-Medina VF, Fatemi O, Serpa J, Valayam J, Bozkurt B, Madjid M, et al. The association between Staphylococcus aureus bacteremia and acute myocardial infarction. Scand J Infect Dis 2009;41:511–514.
35. Anavekar NS, Tleyjeh IM, Anavekar NS, Mirzoyev Z, Steckelberg JM, Haddad C, et al. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis 2007;44:1180–1186.
36. Youssefian T, Drouin A, Masse JM, Guichard J, Cramer EM., Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 2002;99:4021–4029.
37. Kraemer BF, Campbell RA, Schwertz H, Cody MJ, Franks Z, Tolley ND, et al. Novel anti-bacterial activities of beta-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog 2011;7:e1002355.
38. Wuescher LM, Takashima A, Worth RG., A novel conditional platelet depletion mouse model reveals the importance of platelets in protection against Staphylococcus aureus bacteremia. JTH 2015;13:303–313.
39. Zhang X, Liu Y, Gao Y, Dong J, Mu C, Lu Q, et al. Inhibiting platelets aggregation could aggravate the acute infection caused by Staphylococcus aureus. Platelets 2011;22:228–236.
40. Schror K., Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thrombosis Hemostasis 1997;23:349–356.
41. Thomas MR, Storey RF., Effect of P2Y12 inhibitors on inflammation and immunity. Thrombosis Haemostasis 2015;114:490–497.